CTHRC1 is known to have an aberrant expression in many tumor types, such as cancers of the gastrointestinal tract, breast, lung and thyroid, but until now this marker was not investigated in differential diagnostics of NSCLC [31]. Here, CTHRC1 is linked to non-small cell lung carcinoma.